• Press Release

Two Mount Sinai Experts Receive Honors From the National Multiple Sclerosis Society

Fred Lublin, MD, and Aaron Miller, MD, honored with the Hope Award for the impact of their pivotal research and clinical expertise

  • New York, NY
  • (September 16, 2021)

Two of Mount Sinai’s top multiple sclerosis (MS) experts were honored with the prestigious Hope Award at the National Multiple Sclerosis Society’s annual Dinner of Champions, which took place in person at the Edison Ballroom Rooftop on Monday, September 13.

Fred Lublin, MD, Saunders Family Professor of Neurology and Director of The Corinne Goldsmith Dickinson Center for Multiple Sclerosis at Mount Sinai, and Aaron Miller, MD, Professor of Neurology and Medical Director of The Corinne Goldsmith Dickinson Center, were selected for this honor in recognition of their pivotal research and clinical acumen that has inspired hope in the lives of countless MS patients, their families, and the community of people around the country who are affected by this disabling disease.

“Drs. Lublin and Miller are both outstanding clinician-researchers and educators, who have each made indelible impacts on our understanding of and treatment for multiple sclerosis,” said Barbara Vickrey, MD, MPH, Professor and Chair of Neurology at the Icahn School of Medicine at Mount Sinai. “Their tireless commitment to MS patients, their families, and the education of clinicians who care for this community is exemplary. We are proud and grateful to the National Multiple Sclerosis Society for recognizing their excellence with this honor.”

Dr. Lublin is an internationally renowned authority on the scientific and clinical aspects of MS and is one of the foremost authorities regarding experimental therapies. As a neuroimmunologist, he has a special interest in immune functions and abnormalities that affect the nervous system. He has been involved in both clinical and basic science research. A member of many professional societies and advisory boards, Dr. Lublin has previously served as Chairman of the National Multiple Sclerosis Society advisory committee on clinical trials of new MS drugs, Chair of the Clinical Advisory Committee of the New York City chapter of the National Multiple Sclerosis Society, and as a national board member of the Society.

Dr. Miller is a leading neurologist and expert who has held leadership positions for multiple MS programs and professional organizations throughout his illustrious career. Specially trained in neurovirology and immunology, Dr. Miller is the immediate past Chairman of the National Medical Advisory Committee of the National Multiple Sclerosis Society and past president of the Consortium of MS Centers. He was the first president of the Section on Multiple Sclerosis of the American Academy of Neurology and has participated in numerous clinical trials of new treatments for MS. Prior to assuming the position of Medical Director of The Corinne Goldsmith Dickinson Center for Multiple Sclerosis at Mount Sinai in 2004, he spent 23 years leading the Division of Neurology at Maimonides Medical Center. He has authored three books focused on MS, and has served as the editor of Continuum, a continuing education publication of the American Academy of Neurology.

“We are thrilled to honor Drs. Aaron Miller and Fred Lublin as the 2021 Hope Honorees. As global MS research leaders, they have made landmark contributions to how we diagnose and treat MS and to the development of the disease-modifying treatments that have improved the lives of people with MS,” said Tim Coetzee, PhD, Chief Advocacy, Services and Research Officer for the National Multiple Sclerosis Society. “Through their work at The Corinne Goldsmith Dickinson Center for Multiple Sclerosis at Mount Sinai, they have set the standard for delivery of comprehensive, high-quality MS care. Beyond that, they have guided the development of MS specialists who are now leaders in the MS movement and are a source of inspiration and hope for everyone in our movement.”

About the Mount Sinai Health System

The Mount Sinai Health System is New York City's largest academic medical system, encompassing eight hospitals, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region. Mount Sinai advances medicine and health through unrivaled education and translational research and discovery to deliver care that is the safest, highest-quality, most accessible and equitable, and the best value of any health system in the nation. The Health System includes approximately 7,300 primary and specialty care physicians; 13 joint-venture ambulatory surgery centers; more than 415 ambulatory practices throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and more than 30 affiliated community health centers. The Mount Sinai Hospital is ranked on U.S. News & World Report's "Honor Roll" of the top 20 U.S. hospitals and is top in the nation by specialty: No. 1 in Geriatrics and top 20 in Cardiology/Heart Surgery, Diabetes/Endocrinology, Gastroenterology/GI Surgery, Neurology/Neurosurgery, Orthopedics, Pulmonology/Lung Surgery, Rehabilitation, and Urology. New York Eye and Ear Infirmary of Mount Sinai is ranked No. 12 in Ophthalmology. Mount Sinai Kravis Children's Hospital is ranked in U.S. News & World Report’s “Best Children’s Hospitals” among the country’s best in four out of 10 pediatric specialties. The Icahn School of Medicine is one of three medical schools that have earned distinction by multiple indicators: ranked in the top 20 by U.S. News & World Report's "Best Medical Schools," aligned with a U.S. News & World Report "Honor Roll" Hospital, and No. 14 in the nation for National Institutes of Health funding. Newsweek’s “The World’s Best Smart Hospitals” ranks The Mount Sinai Hospital as No. 1 in New York and in the top five globally, and Mount Sinai Morningside in the top 20 globally.

For more information, visit https://www.mountsinai.org or find Mount Sinai on FacebookTwitter and YouTube.